Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.39 USD | +6.88% |
|
+6.21% | +45.88% |
05-15 | ARS Pharmaceuticals, Inc., Q1 2025 Earnings Call, May 14, 2025 | |
05-14 | ARS Pharmaceuticals Q1 Operating Income USD -37.177 Million | RE |
Chart calendar ARS Pharmaceuticals, Inc.
b14c84c4.xw1uOXpv-hfWZhSh7PkffXp4Oj_e1wCP4pjV0Z2blSc.k0YkXhxWrFC0Xnf2v7csSTtJUX2ftC3Cq-Kt5vr1-VLxewhDDFy-VptUYw~38a80cb2b0dbc763f8cc12eb15001158
Upcoming events on ARS Pharmaceuticals, Inc.
Past events on ARS Pharmaceuticals, Inc.
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,32 1,27 3.89% | 0,03 0,01 200% | 89,1 18,5 382.41% | 74,8 | 198 | 347 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -35,5 -76,8 53.78% | -67,5 -76,2 11.36% | -3,08 -61,9 95.02% | -158 | -80,4 | 26,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -34,7 -74,8 53.65% | -54,4 -63,6 14.53% | 8,29 -69,8 111.88% | -149 | -73,9 | 32,1 |
Net income Million USD | Released Forecast Spread | -34,7 -73,2 52.63% | -54,4 -60,8 10.58% | 8,00 -55,8 114.33% | -149 | -73,2 | 28,2 |
EPS USD | Released Forecast Spread | -0,87 -1,33 34.34% | -0,57 -0,64 10.94% | 0,08 -0,58 113.75% | -1,51 | -0,73 | 0,22 |
Announcement Date | 23/03/23 | 21/03/24 | 20/03/25 | - |
Quarterly results
Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,50 0,67 -25% | 2,07 0,58 259.65% | 86,6 15,9 444.53% | 7,97 7,48 6.57% | 12,9 | 26,9 | 27,3 | 22,5 | 45,6 | 79,8 | 55,8 |
EBIT Million USD | Released Forecast Spread | -18,0 -21,0 14.34% | -10,2 -17,5 41.41% | -13,2 -10,2 -28.99% | -15,3 -12,3 -25.12% | -21,7 -20,1 -7.95% | 47,2 -13,7 444.54% | -37,2 -35,3 -5.3% | -48,4 | -45,0 | -27,7 | -40,5 | -42,3 | -20,0 | -56,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,9 -18,8 20.71% | -7,17 -15,0 52.25% | -10,3 -7,49 -37.48% | -12,5 -9,52 -31.46% | -19,1 -17,7 -8.15% | 50,2 -24,1 308.01% | -33,9 -33,2 -2.32% | -46,8 | -43,5 | -26,2 | -38,7 | -40,8 | -18,8 | -55,0 |
Net income Million USD | Released Forecast Spread | -14,9 -17,5 15.21% | -7,17 -13,6 47.33% | -10,3 -10,4 1.45% | -12,5 -11,6 -7.77% | -19,1 -17,2 -11.05% | 49,9 -14,4 446.35% | -33,9 -35,1 3.33% | -46,0 | -44,0 | -25,9 | -38,7 | -40,8 | -18,8 | -55,0 |
EPS USD | Released Forecast Spread | -0,16 -0,18 12.73% | -0,07 -0,14 50% | -0,11 -0,11 0% | -0,13 -0,11 -18.18% | -0,20 -0,15 -35.59% | 0,51 -0,14 464.29% | -0,35 -0,35 -0.96% | -0,48 | -0,43 | -0,26 | -0,35 | -0,31 | -0,11 | -0,16 |
Announcement Date | 09/11/23 | 21/03/24 | 09/05/24 | 06/08/24 | 13/11/24 | 20/03/25 | 14/05/25 | - | - | - | - | - | - | - |
More events
Past sector events for ARS Pharmaceuticals, Inc.
13/06/2025 22:22 | FREEDOM HOLDING CORP.: Q4 2025 Earnings Release |
13/06/2025 13:45 | CHARLES SCHWAB: May 2025 Sales and Revenue Release - Activities Report |
13/06/2025 12:02 | UTILICO EMERGING MARKETS TRUST PLC: Q4 2025 Earnings Release |
13/06/2025 07:00 | OXFORD INSTRUMENTS PLC: Q4 2025 Earnings Release |
13/06/2025 07:00 | AVI GLOBAL TRUST PLC: Q2 2025 Earnings Release |
13/06/2025 06:00 | FRAPORT AG: May 2025 Sales and Revenue Release - Traffic Figures |
12/06/2025 | ASTROSCALE HOLDINGS INC.: Q4 2024 Earnings Release |
12/06/2025 | KURA SUSHI,INC.: Q2 2025 Earnings Release |
12/06/2025 | H.I.S. CO., LTD.: Q2 2025 Earnings Release |
12/06/2025 | J.S.B.CO.,LTD.: Q2 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SPRY Stock
- Calendar ARS Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition